These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Phase I study of corynebacterium parvum in patients with solid tumors. Band PR; Jao-King C; Urtasun RC; Haraphongse M Cancer Chemother Rep; 1975; 59(6):1139-45. PubMed ID: 769953 [TBL] [Abstract][Full Text] [Related]
10. Prolonged fever after pleural instillation of Corynebacterium parvum (Coparvax). Laroche CM; Britton M Thorax; 1987 Oct; 42(10):823-4. PubMed ID: 3424259 [No Abstract] [Full Text] [Related]
11. Proceedings: Immunotherapy of Moloney sarcoma virus tumours in mice with Corynebacterium parvum. Hamilton DN; Bell PR Br J Surg; 1974 Apr; 61(4):321. PubMed ID: 4832648 [No Abstract] [Full Text] [Related]
12. [Preliminary considerations on the intravenous use of Corynebacterium parvum in the treatment of solid neoplasms]. Scheinberg MA; Sartori JP; de Pinho JG AMB Rev Assoc Med Bras; 1979 Apr; 25(4):139-40. PubMed ID: 315598 [No Abstract] [Full Text] [Related]
13. Organ distribution of Corynebacterium parvum labeled with iodine-125. Dimitrov NV; Greenberg CS; Denny T J Natl Cancer Inst; 1977 Feb; 58(2):287-94. PubMed ID: 833877 [TBL] [Abstract][Full Text] [Related]
14. Corynebacterium parvum enhances colonic cancer in dimethylhydrazine-treated rats. Cruse JP; Lewin MR; Clark CG Br J Cancer; 1978 Apr; 37(4):639-43. PubMed ID: 646934 [No Abstract] [Full Text] [Related]
15. The complications of intravenous Corynebacterium parvum infusion. Gill PG; Morris PJ; Kettlewell M Clin Exp Immunol; 1977 Nov; 30(2):229-32. PubMed ID: 606444 [TBL] [Abstract][Full Text] [Related]
16. Preliminary observations on the use of Corynebacterium parvum in patients with primary intracranial tumors: effect on intracranial pressure. Selker RG; Wolmark N; Fisher B; Moore P J Surg Oncol; 1978; 10(4):299-303. PubMed ID: 692136 [TBL] [Abstract][Full Text] [Related]
17. Acute polyarthritis following the use of Corynebacterium parvum vaccine (Coparvax) for malignant pleural effusion. Lever AM; Forsythe J; Oxford P Postgrad Med J; 1983 Dec; 59(698):799-800. PubMed ID: 6657546 [TBL] [Abstract][Full Text] [Related]
18. Metabolic changes following the intravenous infusion of Corynebacterium parvum in man. Royle G; Gill PG Cancer; 1979 Apr; 43(4):1328-30. PubMed ID: 445333 [TBL] [Abstract][Full Text] [Related]
19. Protection by Corynebacterium parvum against tumour cells injected intravenously. Milas L; Mujagić H Rev Eur Etud Clin Biol; 1972 May; 17(5):498-500. PubMed ID: 4648182 [No Abstract] [Full Text] [Related]
20. Studies on the histamine sensitisation produced in mice by Corynebacterium parvum. Adlam C J Med Microbiol; 1973 Nov; 6(4):527-38. PubMed ID: 4357938 [No Abstract] [Full Text] [Related] [Next] [New Search]